Lataa...
Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications
The first report on the antitumor effects of interferon α/β (IFN-I) in mice was published 50 years ago. IFN-α were the first immunotherapeutic drugs approved by the FDA for clinical use in cancer. However, their clinical use occurred at a time when most of their mechanisms of action were still unkno...
Tallennettuna:
| Julkaisussa: | Cancers (Basel) |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6966569/ https://ncbi.nlm.nih.gov/pubmed/31817234 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11121943 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|